These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9382111)

  • 1. Evidence for a major gene controlling susceptibility to tegumentary leishmaniasis in a recently exposed Bolivian population.
    Alcaïs A; Abel L; David C; Torrez ME; Flandre P; Dedet JP
    Am J Hum Genet; 1997 Oct; 61(4):968-79. PubMed ID: 9382111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for onset of cutaneous and mucocutaneous leishmaniasis in Bolivia.
    Alcais A; Abel L; David C; Torrez ME; Flandre P; Dedet JP
    Am J Trop Med Hyg; 1997 Jul; 57(1):79-84. PubMed ID: 9242324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tegumentary leishmaniasis by Leishmania braziliensis complex in Cochabamba, Bolivia including the presence of L. braziliensis outlier: Tegumentary leishmaniasis in Cochabamba, Bolivia: Tegumentary leishmaniasis in Cochabamba, Bolivia.
    Torrico MC; Fernández-Arévalo A; Ballart C; Solano M; Rojas E; Ariza E; Tebar S; Lozano D; Abras A; Gascón J; Picado A; Muñoz C; Torrico F; Gállego M
    Transbound Emerg Dis; 2022 Jul; 69(4):2242-2255. PubMed ID: 34232559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features of cutaneous and disseminated cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis in Paraty, Rio de Janeiro.
    Vieira-Gonçalves R; Pirmez C; Jorge ME; Souza WJ; Oliveira MP; Rutowitsch MS; Da-Cruz AM
    Int J Dermatol; 2008 Sep; 47(9):926-32. PubMed ID: 18937655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous and mucocutaneous leishmaniasis in travellers and migrants: a 20-year GeoSentinel Surveillance Network analysis.
    Boggild AK; Caumes E; Grobusch MP; Schwartz E; Hynes NA; Libman M; Connor BA; Chakrabarti S; Parola P; Keystone JS; Nash T; Showler AJ; Schunk M; Asgeirsson H; Hamer DH; Kain KC;
    J Travel Med; 2019 Dec; 26(8):. PubMed ID: 31553455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leishmaniasis in the major endemic region of Plurinational State of Bolivia: Species identification, phylogeography and drug susceptibility implications.
    Bilbao-Ramos P; Dea-Ayuela MA; Cardenas-Alegría O; Salamanca E; Santalla-Vargas JA; Benito C; Flores N; Bolás-Fernández F
    Acta Trop; 2017 Dec; 176():150-161. PubMed ID: 28751163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucocutaneous leishmaniasis: a clinicopathologic classification.
    Sangueza OP; Sangueza JM; Stiller MJ; Sangueza P
    J Am Acad Dermatol; 1993 Jun; 28(6):927-32. PubMed ID: 8496456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance of Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis to nitric oxide correlates with disease severity in Tegumentary Leishmaniasis.
    Giudice A; Camada I; Leopoldo PT; Pereira JM; Riley LW; Wilson ME; Ho JL; de Jesus AR; Carvalho EM; Almeida RP
    BMC Infect Dis; 2007 Feb; 7():7. PubMed ID: 17316450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The -2518bp promoter polymorphism at CCL2/MCP1 influences susceptibility to mucosal but not localized cutaneous leishmaniasis in Brazil.
    Ramasawmy R; Menezes E; Magalhães A; Oliveira J; Castellucci L; Almeida R; Rosa ME; Guimarães LH; Lessa M; Noronha E; Wilson ME; Jamieson SE; Kalil J; Blackwell JM; Carvalho EM; de Jesus AR
    Infect Genet Evol; 2010 Jul; 10(5):607-13. PubMed ID: 20430117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human genetic susceptibility and infection with Leishmania peruviana.
    Shaw MA; Davies CR; Llanos-Cuentas EA; Collins A
    Am J Hum Genet; 1995 Nov; 57(5):1159-68. PubMed ID: 7485168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parasitological diagnosis of mucocutaneous leishmaniasis due to Leishmania b. braziliensis in Bolivia.
    Dimier-David L; David C; Ravisse P; Bustillos R; Revollo S; Lyèvre P; Muñoz M; Vargas F; Dedet JP
    Rev Soc Bras Med Trop; 1991; 24(4):231-4. PubMed ID: 1845007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous, mucocutaneous and visceral leishmaniasis in Sweden from 1996-2016: a retrospective study of clinical characteristics, treatments and outcomes.
    Glans H; Dotevall L; Söbirk SK; Färnert A; Bradley M
    BMC Infect Dis; 2018 Dec; 18(1):632. PubMed ID: 30526519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular epidemiology and in vitro evidence suggest that Leishmania braziliensis strain helps determine antimony response among American tegumenary leishmaniasis patients.
    Silva SC; Guimarães LH; Silva JA; Magalhães V; Medina L; Queiroz A; Machado PRL; Schriefer A
    Acta Trop; 2018 Feb; 178():34-39. PubMed ID: 29042262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and epidemiological features of leishmaniasis in northwestern-Argentina through a retrospective analysis of recent cases.
    García Bustos MF; González-Prieto G; Ramos F; Mora MC; Hashiguchi Y; Parodi C; Basombrío MA; Moreno S; Monroig S; Beckar J; Jaime D; Sajama J; Yeo M; Marco JD; Locatelli FM; Barrio A
    Acta Trop; 2016 Feb; 154():125-32. PubMed ID: 26611809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of miltefosine for Bolivian cutaneous leishmaniasis.
    Soto J; Rea J; Balderrama M; Toledo J; Soto P; Valda L; Berman JD
    Am J Trop Med Hyg; 2008 Feb; 78(2):210-1. PubMed ID: 18256415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL2RA genetic variants reduce IL-2-dependent responses and aggravate human cutaneous leishmaniasis.
    Oliveira PR; Dessein H; Romano A; Cabantous S; de Brito ME; Santoro F; Pitta MG; Pereira V; Pontes-de-Carvalho LC; Rodrigues V; Rafati S; Argiro L; Dessein AJ
    J Immunol; 2015 Mar; 194(6):2664-72. PubMed ID: 25672756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age modifies the immunologic response and clinical presentation of American tegumentary leishmaniasis.
    Carvalho AM; Amorim CF; Barbosa JL; Lago AS; Carvalho EM
    Am J Trop Med Hyg; 2015 Jun; 92(6):1173-7. PubMed ID: 25918209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal Leishmaniasis in Travelers with Leishmania braziliensis Complex Returning to Israel.
    Solomon M; Sahar N; Pavlotzky F; Barzilai A; Jaffe CL; Nasereddin A; Schwartz E
    Emerg Infect Dis; 2019 Apr; 25(4):642-648. PubMed ID: 30882319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leishmaniasis in Bolivia. II. The involvement of Psychodopygus yucumensis and Psychodopygus llanosmartinsi in the selvatic transmission cycle of Leishmania braziliensis braziliensis in a lowland subandean region.
    Le Pont F; Desjeux P
    Mem Inst Oswaldo Cruz; 1986; 81(3):311-8. PubMed ID: 3574129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parasitological and immunological follow-up of American tegumentary leishmaniasis patients.
    Coutinho SG; Pirmez C; Da-Cruz AM
    Trans R Soc Trop Med Hyg; 2002 Apr; 96 Suppl 1():S173-8. PubMed ID: 12055834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.